Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Hematologic Diseases × Immunotherapy, Adoptive × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Lymphoma, Non-Hodgkin 6 Recurrence 4 Lymphoma, Follicular 3 Lymphoma, B-Cell 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Burkitt Lymphoma 3 Neoplasm, Residual 2 Multiple Myeloma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Glioma 2 Glioblastoma 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Stomach Neoplasms 1 Solid Tumors 1 Simpson-Golabi-Behmel syndrome 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Platinum-Resistant Ovarian Carcinoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

Brentuximab Vedotin 6 dacetuzumab 3 Lenalidomide 3 spartalizumab 2 lintuzumab 2 Doxorubicin 2 Dexamethasone 2 tanespimycin 1 sabatolimab 1 pirtobrutinib 1 fludarabine 1 ficlatuzumab 1 daratumumab 1 Vincristine 1 Vinblastine 1 Thiotepa 1 TAS4464 1 Sertraline 1 Rifampin 1 Prednisone 1 Pam2CSK4 acetate and ODN M362 combination 1 Midazolam 1 Melphalan 1 LCL161 1 Ketoconazole 1 KW-2478 1 Immunotherapy, Adoptive 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04180059 2026-01-26

CTL-DP 01

Nantes University Hospital

Phase 1 Recruiting

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡